| Yasmin Dosages & Strengths | ||||
|---|---|---|---|---|
| Strength | Format | Route | Strength | Class |
| Yasmin 3 mg-0.03 mg | tablet | oral | 1.0 each | OTC |
Posted by yulia about 4 hours ago
I just came back from my GP and I am off work now until the end of the week and it's all because of Yasmin. I decided to go o...
Posted by arianna about 4 hours ago
I have only been taking Yasmin for a week. I am a healthy 35 year old woman and had not taken the pill in over 7 years. It is...
Posted by goodkitty7 about 9 hours ago
I posted here on July 15, and would like to update.
(I had been on Yasmin for 3 years and got off it at the end of June, the...
UNICEF/EU officials on Guinea Worm assessment tour - The Statesman Online
The Ambassador for European Commission Directorate for Humanitarian Aid Office, Filberto Seberigondi and UNICEF Ghana Country Representative Yasmin Ali ...
Mon Mar 10 04:33:01 -0400 2008
Le Bon campaigns against fake goods - The Press Association
The real model - Yasmin Le Bon, wife of pop star Simon - was there to launch a major global campaign to combat the rising tide of counterfeiting and piracy ...
Mon Mar 10 06:15:46 -0400 2008
Yasmin Alibhai-Brown: Powell's Rivers of Blood are back again - Independent
Back in the spring of 1968, East African Asians were adjusting to the retreat of colonialism. We were, remember, the essential middle-class buffer between ...
Sun Mar 09 21:44:35 -0400 2008
ethinyl estradiol - A semisynthetic estrogen. Ethinyl estradiol binds to the estrogen receptor complex and enters the nucleus, activating DNA transcription of genes involved in estrogenic cellular responses. This agent also inhibits 5-alpha reductase in epididymal tissue, which lowers testosterone levels and may delay progression of prostatic cancer. In addition to its antineoplastic effects, ethinyl estradiol protects against osteoporosis. In animal models, short-term therapy with this agent has been shown to provide long-term protection against breast cancer, mimicking the antitumor effects of pregnancy. (NCI04)
drospirenone - A synthetic spironolactone analogue and progestin with progestational and anti-mineralocorticoid activity. Drospirenone binds to the progesterone receptor, the resulting complex becomes activated and binds to specific sites on DNA. This results in a suppression of LH activity and an inhibition of ovulation as well as an alteration in the cervical mucus and endometrium. This leads to an increased difficulty of sperm entry into the uterus and implantation. This drug is used in oral contraceptives.